Vaccinology: The art of putting together the right ingredients
Authors:
Open Access
- 11 January 2016
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 12 (5) , 1311-1317
Abstract
Historically vaccines were produced using whole attenuated or killed pathogens and still a large proportion of current vaccines utilizes such procedure. However, for safety and quality reasons the development of novel vaccines is preferentially based on the selection and use of specific pathogen components which alone are capable of eliciting protective immune responses against the pathogens they derived from. The big challenge for vaccinologists is how to select the right antigens and to combine them with proper immune stimulatory components (adjuvants) in order to induce protective immunity. This Commentary outlines the authors' view on the current and future strategies for the efficient and rapid identification of the most effective protective antigens and adjuvants. Since efficacious subunit-based vaccines against recalcitrant pathogens are likely to require more than one antigen and/or immune stimulator, this poses the problem of how to make such vaccines economically acceptable. In this regard, the authors also present their view of how bacterial Outer Membrane Vesicles (OMVs) could become a promising platform for the development of future vaccines. The unique properties of OMVs might be exploited in the field of infectious diseases and oncology.Keywords
This publication has 39 references indexed in Scilit:
- Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functionsNature Reviews Microbiology, 2015
- Decoration of Outer Membrane Vesicles with Multiple Antigens by Using an Autotransporter ApproachApplied and Environmental Microbiology, 2014
- Improved delivery of the OVA-CD4 peptide to T helper cells by polymeric surface display on SalmonellaMicrobial Cell Factories, 2014
- Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitroJournal of Extracellular Vesicles, 2013
- Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus CaseMolecular & Cellular Proteomics, 2012
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodesVaccine, 2011
- Profiling the surfacome of Staphylococcus aureusProteomics, 2010
- Recombinant outer membrane vesicles to augment antigen-specific live vaccine responsesVaccine, 2009
- Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram‐positive bacteriaProteomics, 2008
- Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome ScreenScience, 2005